Literature DB >> 22642538

Cationic porphyrins are reversible proteasome inhibitors.

Anna Maria Santoro1, Maria Cristina Lo Giudice, Alessandro D'Urso, Rosaria Lauceri, Roberto Purrello, Danilo Milardi.   

Abstract

The aim of this study is to verify if water-soluble porphyrins can be used as proteasome inhibitors. We have found that cationic porphyrins inhibit proteasome peptidase activities much more effectively than the corresponding anionic derivatives. The relevance of electrostatics in driving porphyin-proteasome interactions has been confirmed by the observation that the inhibitory efficiency of the cationic macrocycles decreases with the number of positive substituents. We have also investigated various metalloporphyrins, which differ due to the different propension of the central metal ion toward axial coordination. Our experimental results indicate that the naked cationic porphyrins are the most active in reversibly inhibiting the three main protease activities of the proteasome in the micromolar range. A spectroscopic characterization of porphyrin-proteasome interactions by UV-vis spectra parallels the results of inhibition assays: the higher the inhibitory effect the stronger the spectroscopic variations are. To interpret the action of porphyrins at a molecular level, we have performed calculations evidencing that cationic porphyrins may hinder the access to the canonical proteolytic site on the proteasome β5 subunit. In particular, an inspection of the top-scoring docking modes shows that the tetracationic porphyrin blocks the catalytic pocket, close to the N termini of the β5 proteasome subunit, more efficiently than its anionic counterpart. Proteasome inhibition activity of porphyrins unites their known anticancer properties making them suitable as a scaffold for the design of novel multitargeted molecules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22642538     DOI: 10.1021/ja300781u

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  17 in total

1.  Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes.

Authors:  Marc Pfefferlé; Giada Ingoglia; Christian A Schaer; Ayla Yalamanoglu; Raphael Buzzi; Irina L Dubach; Ge Tan; Emilio Y López-Cano; Nadja Schulthess; Kerstin Hansen; Rok Humar; Dominik J Schaer; Florence Vallelian
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

2.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

Review 3.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

4.  Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study.

Authors:  Anna Maria Santoro; Irene Monaco; Francesco Attanasio; Valeria Lanza; Giuseppe Pappalardo; Marianna Flora Tomasello; Alessandra Cunsolo; Enrico Rizzarelli; Ada De Luigi; Mario Salmona; Danilo Milardi
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

5.  Cationic porphyrins are tunable gatekeepers of the 20S proteasome.

Authors:  Anna M Santoro; Alessandra Cunsolo; Alessandro D'Urso; Diego Sbardella; Grazia R Tundo; Chiara Ciaccio; Massimiliano Coletta; Donatella Diana; Roberto Fattorusso; Marco Persico; Antonio Di Dato; Caterina Fattorusso; Danilo Milardi; Roberto Purrello
Journal:  Chem Sci       Date:  2015-11-09       Impact factor: 9.825

Review 6.  Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.

Authors:  Romina A Guedes; Patrícia Serra; Jorge A R Salvador; Rita C Guedes
Journal:  Molecules       Date:  2016-07-16       Impact factor: 4.411

7.  Proteasome inhibition and oxidative reactions disrupt cellular homeostasis during heme stress.

Authors:  F Vallelian; J W Deuel; L Opitz; C A Schaer; M Puglia; M Lönn; W Engelsberger; S Schauer; E Karnaukhova; D R Spahn; R Stocker; P W Buehler; D J Schaer
Journal:  Cell Death Differ       Date:  2014-10-10       Impact factor: 15.828

8.  Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response.

Authors:  J W Deuel; C A Schaer; F S Boretti; L Opitz; I Garcia-Rubio; J H Baek; D R Spahn; P W Buehler; D J Schaer
Journal:  Cell Death Dis       Date:  2016-01-21       Impact factor: 8.469

Review 9.  The 26S proteasome is a multifaceted target for anti-cancer therapies.

Authors:  Tatyana A Grigoreva; Vyacheslav G Tribulovich; Alexander V Garabadzhiu; Gerry Melino; Nickolai A Barlev
Journal:  Oncotarget       Date:  2015-09-22

10.  Electrostatic Map Of Proteasome α-Rings Encodes The Design of Allosteric Porphyrin-Based Inhibitors Able To Affect 20S Conformation By Cooperative Binding.

Authors:  Antonio Di Dato; Alessandra Cunsolo; Marco Persico; Anna Maria Santoro; Alessandro D'Urso; Danilo Milardi; Roberto Purrello; Manuela Stefanelli; Roberto Paolesse; Grazia R Tundo; Diego Sbardella; Caterina Fattorusso; Massimo Coletta
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.